Austar Lifesciences Limited (HKG:6118)

Austar Lifesciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,461	1,500	1,764	2,157	2,015	1,296
Revenue Growth (YoY)	-5.42%	-14.93%	-18.23%	7.04%	55.48%	23.54%
Cost of Revenue	1,166	1,199	1,428	1,668	1,536	972.45
Gross Profit	294.94	301.22	336.05	488.8	479.01	323.53
Selling, General & Admin	238.05	239.08	300.99	305.93	298.38	247.39
Research & Development	46.56	53.55	55.33	70.16	65.6	48.27
Other Operating Expenses	-24.04	-25.97	-11.15	-6.94	-7.63	-10.44
Operating Expenses	259.34	266.45	377.26	366.01	362.04	297.15
Operating Income	35.6	34.77	-41.21	122.79	116.97	26.38
Interest Expense	-14.46	-17.01	-13.96	-9.59	-4.4	-2.79
Interest & Investment Income	2.19	2.9	3.29	2.27	1.47	3.12
Earnings From Equity Investments	2.07	0.3	6.73	9.54	10.66	10.48
Currency Exchange Gain (Loss)	9.88	-4.1	6.83	-5.17	-3.74	4.36
Other Non Operating Income (Expenses)	-0.19	-0.19	-0.19	-	-	-
EBT Excluding Unusual Items	35.09	16.67	-38.51	119.83	120.95	41.54
Gain (Loss) on Sale of Investments	-0.42	-0.42	-	-	198.99	-
Gain (Loss) on Sale of Assets	-0.58	-0.2	4.1	-0.3	-0.72	-0.05
Other Unusual Items	8.2	5.13	-	-	-	-
Pretax Income	42.29	21.17	-34.41	119.53	319.23	41.49
Income Tax Expense	9.29	7.6	0.38	18.89	46.6	9.88
Earnings From Continuing Operations	33	13.57	-34.79	100.64	272.62	31.61
Earnings From Discontinued Operations	-	-	-80.87	-16.78	-	-
Net Income to Company	33	13.57	-115.66	83.86	272.62	31.61
Minority Interest in Earnings	2.2	2.51	2.18	3.6	4.68	1.5
Net Income	35.2	16.08	-113.47	87.46	277.3	33.1
Net Income to Common	35.2	16.08	-113.47	87.46	277.3	33.1
Net Income Growth	-	-	-	-68.46%	737.76%	309.10%
Shares Outstanding (Basic)	513	513	513	513	513	513
Shares Outstanding (Diluted)	513	513	513	513	513	513
EPS (Basic)	0.07	0.03	-0.22	0.17	0.54	0.06
EPS (Diluted)	0.07	0.03	-0.22	0.17	0.54	0.06
EPS Growth	-	-	-	-68.40%	800.00%	280.13%
Free Cash Flow	92.04	78.31	-131.88	-155.04	-204.02	25.68
Free Cash Flow Per Share	0.18	0.15	-0.26	-0.30	-0.40	0.05
Gross Margin	20.18%	20.08%	19.05%	22.66%	23.77%	24.96%
Operating Margin	2.44%	2.32%	-2.34%	5.69%	5.80%	2.04%
Profit Margin	2.41%	1.07%	-6.43%	4.06%	13.76%	2.55%
Free Cash Flow Margin	6.30%	5.22%	-7.48%	-7.19%	-10.13%	1.98%
EBITDA	66.64	65.07	-19.82	137.06	130.62	39.83
EBITDA Margin	4.56%	4.34%	-1.12%	6.35%	6.48%	3.07%
D&A For EBITDA	31.04	30.29	21.4	14.27	13.65	13.45
EBIT	35.6	34.77	-41.21	122.79	116.97	26.38
EBIT Margin	2.44%	2.32%	-2.34%	5.69%	5.80%	2.04%
Effective Tax Rate	21.97%	35.90%	-	15.81%	14.60%	23.82%
Advertising Expenses	-	6.55	8.6	5.83	12.76	12.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.